Recoflavone
Based on 1 Customer Validation
Recoflavone (DA-6034 (free acid)), a synthetic derivative of the flavonoid Eupatilin (HY-N0783), is orally active. Recoflavone can inhibit the NF-κB pathway and induce [Ca(2+)]i increase in epithelial cells. Recoflavone exhibits activities such as anti-inflammation, anti-tumor effects, protection of gastric and intestinal mucosa, and promotion of secretion in the ocular surface and salivary glands. Recoflavone can be used for the research of diseases such as dry eye, gastric injury, and intestinal injury.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.0%
- CAS No.: 203191-10-0
- Formule: C20H18O8
- Masse moléculaire:386.35
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Voir tous les produits spécifiques à Isoform Calcium Channel
More
Activité biologique
Recoflavone (100-250 µM; 24-48 h) increases mucin-like glycoprotein secretion in human corneal epithelial cells[1].
Recoflavone (200 µM; 24 h) significantly increases the production of several mucins including MUC1, MUC2, MUC4, MUC5AC, MUC5B and MUC16 in human conjunctival epithelial cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Recoflavone (30 mg/kg; oral administration; once every 12 hours; 3 days) exhibits protective effects in a rat small intestinal injury model[2].
Recoflavone (30 mg/kg; oral gavage; twice daily; from day 7 to day 63) shows improvement effects in a mouse colitis-associated cancer model[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male New Zealand White rabbits (2.5 kg) with desiccation-induced dry eye by keeping eyes open with a specula for 2 h[1]
-
Dosage:3 %
-
Administration:Eye drops; single dose
-
Result:Significantly decreased methylene blue permeability in the cornea compared to the vehicle-treated group, indicating prevention of desiccation-induced corneal damage.
-
Animal Model:Sprague-Dawley rats aged 6 weeks old (250 g) treated Indomethacin (HY-14397) to induce small intestinal injury[2]
-
Dosage:30 mg/kg
-
Administration:Oral administration; once every 12 hours; 3 days
-
Result:Increased the ERK expression.
Had significantly lower intestinal permeability compared with the control group, while the inflammation scores and the extent of hemorrhagic lesions showed no statistically significant differences.
-
Animal Model:C57BL/6 mice aged 10 weeks old (18-21 g) treated AOM (HY-111375) and DSS (HY-116282C) to induce colitis-associated cancer[3]
-
Dosage:30 mg/kg
-
Administration:Oral gavage; twice daily; from day 7 to day 63
-
Result:Reduced the number of colon tumors.
Ameliorated weight loss and colon shortening.
Enhanced apoptosis , and inhibited the expression of proliferation marker Ki-67, COX-2, and phospho-IKKα in colon tissue.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 203191-10-0
-
Appearance Solid
-
Masse moléculaire 386.35
-
Formule C20H18O8
-
Color Off-white to light yellow
-
SMILES
COC1=C2C(OC(C3=CC(OC)=C(OC)C=C3)=CC2=O)=CC(OCC(O)=O)=C1
-
Synonyms
DA-6034 free acid
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 40 mg/mL (103.53 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (277 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Choi SM, et al. Effects of DA-6034, a flavonoid derivative, on mucin-like glycoprotein and ocular surface integrity in a rabbit model. Arzneimittelforschung. 2009;59(10):498-503. ;Kwak DS, Lee OY, Lee KN, et al. The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model. Gut Liver. 2016;10(3):406-411. [Content Brief]
[2]. Kwak DS, Lee OY, Lee KN, et al. The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model. Gut Liver. 2016;10(3):406-411. ;Kim YW, Lee WH, Choi SM, et al. DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway. J Gastroenterol Hepatol. 2012;27(2):397-405. [Content Brief]
[3]. Nam SY, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood). 2008;233(2):180-191. [Content Brief]
[4]. Yang YM, et al. DA-6034 Induces [Ca(2+)]i Increase in Epithelial Cells. Korean J Physiol Pharmacol. 2014 Apr;18(2):89-94. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5883 mL | 12.9416 mL | 25.8833 mL | 64.7082 mL |
| 5 mM | 0.5177 mL | 2.5883 mL | 5.1767 mL | 12.9416 mL | |
| 10 mM | 0.2588 mL | 1.2942 mL | 2.5883 mL | 6.4708 mL | |
| 15 mM | 0.1726 mL | 0.8628 mL | 1.7256 mL | 4.3139 mL | |
| 20 mM | 0.1294 mL | 0.6471 mL | 1.2942 mL | 3.2354 mL | |
| 25 mM | 0.1035 mL | 0.5177 mL | 1.0353 mL | 2.5883 mL | |
| 30 mM | 0.0863 mL | 0.4314 mL | 0.8628 mL | 2.1569 mL | |
| 40 mM | 0.0647 mL | 0.3235 mL | 0.6471 mL | 1.6177 mL | |
| 50 mM | 0.0518 mL | 0.2588 mL | 0.5177 mL | 1.2942 mL | |
| 60 mM | 0.0431 mL | 0.2157 mL | 0.4314 mL | 1.0785 mL | |
| 80 mM | 0.0324 mL | 0.1618 mL | 0.3235 mL | 0.8089 mL | |
| 100 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.6471 mL |